Overview
About Biolidics
Board of Directors
Key Executive Officer
Oncology
Oncology
Products
Resources And Publications
Request for a Quotation
Investor Relations
IR Home
Reports
Announcements
Stock Information
Email Alerts
Contact
Corporate Office
Careers Opportunity
Personal Data Policy
Whistle Blowing Policy
News
Back
27 Mar 2020
Completion of Proposed Placement of 17,858,000 New Ordinary Shares in the Capital of Biolidics
Attachment 1
Locate Us
Contact Us
Enquiry Form
Whatsapp Us